IDH1 and central nervous system cancer: The synergy of DL with dynamic susceptibility contrast (DSC) MRI was also confirmed in 2024 through an interesting study involving relative cerebral blood volume (rCBV) characteristics; pre-trained and attention gate-enhanced CNNs managed to outperform classical ML models in all outcome components not merely for IDH-mutated, but for TERT gene promoter (TERTp)-mutated gliomas as well [102].